179
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Cancer-associated Retinopathy with Retinal Periphlebitis in a Patient with Ovarian Cancer

, MD, , MD, , PhD & , MD
Pages 107-109 | Received 29 Jul 2009, Accepted 02 Nov 2009, Published online: 06 Apr 2010

REFERENCES

  • Chan JW. Paraneoplastic retinopathies and optic neuropathies. Surv Ophthalmol. 2003;48:12–38.
  • Ohnishi Y, Ohara S, Sakamoto T, et al. Cancer-associated retinopathy with retinal phlebitis. Br J Ophthalmol. 1993;77:795–798.
  • Goetgebuer G, Kestelyn-Stevens AM, De Laey JJ, et al. Cancer-associated retinopathy (CAR) with negative-type ERG: a case report. Doc Ophthalmol. 2008;116:49–55.
  • Audo I, Robson AG, Holder GE, et al. The negative ERG: clinical phenotypes and disease mechanisms of inner retinal dysfunction. Surv Ophthalmol. 2008;53:16–40.
  • Harmon JP, Purvin VA, Guy J, et al. Cancer-associated retinopathy in a patient with advanced epithelial ovarian carcinoma. Gynecol Oncol. 1999;73:430–432.
  • Yoon YH, Cho EH, Sohn J, et al. An unusual type of cancer-associated retinopathy in a patient with ovarian cancer. Korean J Ophthalmol. 1999;13:43–48.
  • Adamus G. Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy retinopathy. Autoimmun Rev. 2003;2:63–69.
  • Dot C, Guigay J, Adamus G. Anti-α-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung. Am J Ophthalmol. 2005;139:746–747.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.